Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Express Scripts
Merck
AstraZeneca
Mallinckrodt

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

West-ward Pharms Int Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WEST-WARD PHARMS INT, and what generic and branded alternatives to WEST-WARD PHARMS INT drugs are available?

WEST-WARD PHARMS INT has three hundred and fifty-three approved drugs.

There are two tentative approvals on WEST-WARD PHARMS INT drugs.

Summary for West-ward Pharms Int
US Patents:0
Tradenames:233
Ingredients:209
NDAs:353

Drugs and US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int TOBRAMYCIN SULFATE tobramycin sulfate INJECTABLE;INJECTION 063117-001 Apr 26, 1991 AP RX No No   Start Trial   Start Trial
West-ward Pharms Int DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 064097-001 Sep 13, 1994 AP RX No No   Start Trial   Start Trial
West-ward Pharms Int FLUCONAZOLE IN SODIUM CHLORIDE 0.9% fluconazole INJECTABLE;INJECTION 076087-003 Jul 29, 2004 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 3,947,569   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-002 Sep 30, 1982 4,110,438   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 3,947,569   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Moodys
Mallinckrodt
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.